Xencor (XNCR) Short term Debt (2023 - 2026)

Xencor (XNCR) reported Short term Debt of $26.4 million for Q1 2026, down 49.74% year-over-year from $52.5 million in Q1 2025, and down 38.96% quarter-over-quarter from $43.3 million in Q4 2025.

Xencor (XNCR) Short term Debt (2023 - 2026) Analysis & Trends

Xencor (XNCR) has 4 years of Short term Debt data on file, last reported at $26.4 million in Q1 2026.

  • Short term Debt for Q1 2026 came in at $26.4 million, down 49.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.4 million (down 49.74% YoY), and the FY2025 annual result was $43.3 million, down 10.69% from the prior year.
  • Short term Debt retreated to $26.4 million in Q1 2026 per XNCR's latest filing, from $43.3 million in the prior quarter.
  • Over five years, Short term Debt peaked at $52.5 million in Q1 2025 and troughed at $26.4 million in Q1 2026.
  • A 4-year average of $41.2 million and a median of $43.9 million in 2024 frame the typical range for Short term Debt.
  • The sharpest annual moves came in 2024 and 2026: Short term Debt jumped 74.83% in 2024, then tumbled 49.74% in 2026.
  • A 4-year view of Short term Debt shows it stood at $27.7 million in 2023, then jumped by 74.83% to $48.4 million in 2024, then retreated by 10.69% to $43.3 million in 2025, then plunged by 38.96% to $26.4 million in 2026.
  • Business Quant data shows XNCR's Short term Debt at $26.4 million in Q1 2026, $43.3 million in Q4 2025, and $45.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Xencor 953.38 Mn 878.64 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 26.41 Mn
Dec 31, 2025 43.27 Mn
Sep 30, 2025 45.36 Mn
Jun 30, 2025 50.29 Mn
Mar 31, 2025 52.54 Mn
Dec 31, 2024 48.45 Mn
Sep 30, 2024 44.46 Mn
Jun 30, 2024 38.93 Mn
Mar 31, 2024 34.20 Mn
Dec 31, 2023 27.71 Mn